Abstract P5-12-01: Predicting the effect of tamoxifen on the breast: Change in measures of breast density, serum markers and SNPs
Anthony Howell(Breast Cancer Care), D. Gareth Evans(Manchester Academic Health Science Centre), Jack Cuzick(Queen Mary University of London), Ursula Beetles(Manchester Academic Health Science Centre), Jill Fox, Mary Wilson(St Mary's Hospital), Elaine F. Harkness(Manchester Academic Health Science Centre), Valerie Reece(Breast Cancer Care), Ruth Warren(University of Cambridge), Paula Stavrinos(Breast Cancer Research Foundation), Yit Yoong Lim(Wythenshawe Hospital), Sue Astley(University of Manchester), Julia Wiseman, Anil Jain(Manchester Academic Health Science Centre), Jamie C. Sergeant(Manchester Academic Health Science Centre)
Cited by 1
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
|JNCI Journal of the National Cancer Institute|2013|946